Dynamical changes in neurological diseases and anesthesia

Current Opinion in Neurobiology

Volumn 22, Issue 4, 2012, Pages 693-703

  McCarthy, Michelle M ^a   Ching, ShiNung ^a,b,c   Whittington, Miles A ^d   Kopell, Nancy ^a  

^a Boston University   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; DOPAMINE; ENFLURANE; ETOMIDATE; ISOFLURANE; NITROUS OXIDE; PROPOFOL; ZOLPIDEM;

AUDITORY CORTEX; BETA RHYTHM; BRAIN FUNCTION; BRAIN REGION; COGNITIVE DEFECT; COMPUTER MODEL; CORPUS STRIATUM; DOPAMINE METABOLISM; DYSBINDIN 1 GENE; ENTORHINAL CORTEX; GABAERGIC SYSTEM; GAMMA RHYTHM; GENE; GENERAL ANESTHESIA; GENETIC SUSCEPTIBILITY; HUMAN; NERVE CELL MEMBRANE POTENTIAL; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NEUROMODULATION; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION; VISUAL CORTEX;

ANESTHESIA; ANESTHETICS; GAMMA-AMINOBUTYRIC ACID; HUMANS; MODELS, NEUROLOGICAL; NERVE NET; NERVOUS SYSTEM DISEASES; NEURONS; NONLINEAR DYNAMICS;

EID: 84865957580     PISSN: 09594388     EISSN: 18736882     Source Type: Journal    
DOI: 10.1016/j.conb.2012.02.009     Document Type: Review

References (86)

1. Doyle L.M.F., Kuhn A.A., Hariz M., Kupsch A., Schneider G.H., Brown P. Levodopa-induced modulation of subthalamic beta oscillations during self-paced movements in patients with Parkinson's disease. Eur J Neurosci 2005, 21:1403-1412.
2. Hammond C., Bergman H., Brown P. Pathological synchronization in Parkinson's disease: networks, models and treatments. Trends Neurosci 2007, 30:357-364.
3. Weinberger M., Mahant N., Hutchison W.D., Lozano A.M., Moro E., Hodaie M., Lang A.E., Dostrovsky J.O. Beta oscillatory activity in the subthalamic nucleus and its relation to dopaminergic response in Parkinson's disease. J Neurophysiol 2006, 96:3248-3256.
4. Silberstein P., Pogosyan A., Kuhn A.A., Hotton G., Tisch S., Kupsch A., Dowsey-Limousin P., Hariz M.I., Brown P. Cortico-cortical coupling in Parkinson's disease and its modulation by therapy. Brain 2005, 128:1277-1291.
5. Kühn A.A., Tsui A., Aziz T., Ray N., Brücke C., Kupsch A., Schneider G.H., Brown P. Pathological synchronisation in the subthalamic nucleus of patients with Parkinson's disease relates to both bradykinesia and rigidity. Exp Neurol 2009, 215:380-387.
6. Courtemanche R., Fujii N., Graybiel A.M. Synchronous, focally modulated β-band oscillations characterize local field potential activity in the striatum of awake behaving monkeys. J Neurosci 2003, 23:11741-11752.
7. Devos D., Szurhaj W., Reyns N., Labyt E., Houdayer E., Bourriez J.L., Cassim F., Krystkowiak P., Blond S., Destée A., et al. Predominance of the contralateral movement-related activity in the subthalamo-cortical loop. Clin Neurophysiol 2006, 117:2315-2327.
8. Brücke C., Kempf F., Kupsch A., Schneider G.H., Krauss J.K., Aziz T., Yarrow K., Pogosyan A., Brown P., Kühn A.A. Movement-related synchronization of gamma activity is lateralized in patients with dystonia. Eur J Neurosci 2008, 27:2322-2329.
9. Sochurkova D., Rektor I. Event-related desynchronization/synchronization in the putamen. An SEEG case study. Exp Brain Res 2003, 149:401-404.
10. Mallet N., Pogosyan A., Sharott A., Csicsvari J., Bolam J.P., Brown P., Magill P.J. Disrupted dopamine transmission and the emergence of exaggerated beta oscillations in subthalamic nucleus and cerebral cortex. J Neurosci 2008, 28:4795-4806.
11. Gittis A.H., Hang G.B., LaDow E.S., Shoenfeld L.R., Atallah B.V., Finkbeiner S., Kreitzer A.C. Rapid target-specific remodeling of fast-spiking inhibitory circuits after loss of dopamine. Neuron 2011, 71:858-868.
12. Tepper J.M., Bolam J.P. Functional diversity and specificity of neostriatal interneurons. Curr Opin Neurobiol 2004, 14:685-692.
13. McCarthy M.M., Moore-Kochlacs C., Gu X., Boyden E.S., Han X., Kopell N. Striatal origin of the pathologic beta oscillations in Parkinson's disease. Proc Natl Acad Sci U S A 2011, 108:11620-11625.
14. DeBoer P., Heeringa M.J., Abercrombie E.D. Spontaneous release of acetylcholine in striatum is preferentially regulated by inhibitory dopamine D2 receptors. Eur J Pharmacol 1996, 317:257-262.
15. Ikarashi Y., Takahashi A., Ishimaru H., Arai T., Maruyama Y. Regulation of dopamine D1 and D2 receptors on striatal acetylcholine release in rats. Brain Res Bull 1997, 43:107-115.
16. Koós T., Tepper J.M. Dual cholinergic control of fast-spiking interneurons in the neostriatum. J Neurosci 2002, 22:529-535.
17. Chan C.S., Glajch K.E., Gertler T.S., Guzman J.N., Mercer J.N., Lewis A.S., Goldberg A.B., Tkatch T., Shigemoto R., Fleming S.M., et al. HCN channelopathy in external globus pallidus neurons in models of Parkinson's disease. Nat Neurosci 2011, 14:85-92.
18. Kravitz A.V., Freeze B.S., Parker P.R.L., Kay D., Thwin M.T., Deisseroth K., Kreitzer A.C. Regulation of parkinsonian motor behaviors by optogenetic control of basal ganglia circuitry. Nature 2010, 466:622-626.
19. Kreitzer A.C. Physiology and pharmacology of striatal neurons. Annu Rev Neurosci 2009, 32:127-147.
20. Rommelfanger K.S., Wichmann T. Extrastriatal dopaminergic circuits of the basal ganglia. Front Neuroanat 2010, 4:139.
21. Rubin J.E., Terman D. High frequency stimulation of the subthalamic nucleus eliminates pathological thalamic rhythmicity in a computational model. J Comput Neurosci 2004, 16:211-235.
22. Plenz D., Kitai S. A basal ganglia pacemaker formed by the subthalamic nucleus and external globus pallidus. Nature 1999, 400:677-682.
23. Terman D., Rubin J.E., Yew A.C., Wilson C.J. Activity patterns in a model for the subthalamopallidal network of the basal ganglia. J Neurosci 2002, 22:2963-2976.
24. So RQ, Kent AR, Grill WM: Relative contributions of local cell and passing fiber activation and silencing to changes in thalamic fidelity during deep brain stimulation and lesioning: a computational modeling study. J Comput Neurosci 2011, Oct. 5 [Epub ahead of print].
25. Yamawaki N., Stanford I.M., Hall S.D., Woodhall G.L. Pharmacologically induced and stimulus evoked rhythmic neuronal oscillatory activity in the primary motor cortex in vitro. Neuroscience 2008, 151:386-395.
26. Roopun A.K., Middleton S.J., Cunningham M.O., LeBeau F.E.N., Bibbig A., Whittington M.A., Traub R.D. A beta2-frequency (20-30Hz) oscillation in nonsynaptic networks of somatosensory cortex. Proc Natl Acad Sci U S A 2006, 103:15646-15650.
27. Uhlhaas P.J., Singer W. The development of neural synchrony and large-scale cortical networks during adolescence: relevance for the pathophysiology of schizophrenia and neurodevelopmental hypothesis. Schizophr Bull 2011, 37:514-523.
28. Douaud G., Mackay C., Andersson J., James S., Quested D., Ray M.K., Connell J., Roberts N., Crow T.J., Matthews P.M., et al. Schizophrenia delays and alters maturation of the brain in adolescence. Brain 2009, 132:2437-2448.
29. de Achával D., Villarreal M.F., Costanzo E.Y., Douer J., Castro M.N., Mora M.C., Nemeroff C.B., Chu E., Bär K.J., Guinjoan S.M. Decreased activity in right-hemisphere structures involved in social cognition in siblings discordant for schizophrenia. Schizophr Res 2011, (e-pub).
30. Xu L., Adali T., Schretlen D., Pearlson G., Calhoun V.D. Structural angle and power images reveal interrelated gray and white matter abnormalities in schizophrenia. Neurol Res Int 2012, 2012:735249.
31. Olabi B., Ellison-Wright I., McIntosh A.M., Wood S.J., Bullmore E., Lawrie S.M. Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies. Biol Psychiatry 2011, 70:88-96.
32. Chan M.K., Tsang T.M., Harris L.W., Guest P.C., Holmes E., Bahn S. Evidence for disease and antipsychotic medication effects in post-mortem brain from schizophrenia patients. Mol Psychiatry 2011, 16:1189-1202.
33. Bassett D.S., Nelson B.G., Mueller B.A., Camchong J., Lim K.O. Altered resting state complexity in schizophrenia. Neuroimage 2011, (e-pub).
34. Alexander-Bloch A., Lambiotte R., Roberts B., Giedd J., Gogtay N., Bullmore E. The discovery of population differences in network community structure: new methods and applications to brain functional networks in schizophrenia. Neuroimage 2011, (e-pub).
35. Tognin S., Viding E., McCrory E.J., Taylor L., O'Donovan M.C., McGuire P., Mechelli A. Effects of DTNBP1 genotype on brain development in children. J Child Psychol Psychiatry 2011, 52:1287-1294.
36. Carlson G.C., Talbot K., Halene T.B., Gandal M.J., Kazi H.A., Schlosser L., Phung Q.H., Gur R.E., Arnold S.E., Siegel S.J. Dysbindin-1 mutant mice implicate reduced fast-phasic inhibition as a final common disease mechanism in schizophrenia. Proc Natl Acad Sci U S A 2011, 108:E962-E970.
37. Rokem A., Yoon J.H., Ooms R.E., Maddock R.J., Minzenberg M.J., Silver M.A. Broader visual orientation tuning in patients with schizophrenia. Front Hum Neurosci 2011, 5:127.
38. Roopun A.K., Lebeau F.E., Ramell J., Cunningham M.O., Traub R.D., Whittington M.A. Cholinergic neuromodulation controls directed temporal communication in neocortex in vitro. Front Neural Circuits 2010, 4:8.
39. Wulff P., Ponomarenko A.A., Bartos M., Korotkova T.M., Fuchs E.C., Bähner F., Both M., Tort A.B., Kopell N.J., Wisden W., Monyer H. Hippocampal theta rhythm and its coupling with gamma oscillations require fast inhibition onto parvalbumin-positive interneurons. Proc Natl Acad Sci U S A 2009, 106:3561-3566.
40. Whittington M.A., Cunningham M.O., LeBeau F.E., Racca C., Traub R.D. Multiple origins of the cortical gamma rhythm. Dev Neurobiol 2011, 71:92-106.
41. Gonzalez-Burgos G., Fish K.N., Lewis D.A. GABA neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia. Neural Plast 2011, 2011:723184.
42. Roopun A.K., Cunningham M.O., Racca C., Alter K., Traub R.D., Whittington M.A. Region-specific changes in gamma and beta2 rhythms in NMDA receptor dysfunction models of schizophrenia. Schizophr Bull 2008, 34:962-973.
43. Fries P. A mechanism for cognitive dynamics: neuronal communication through neuronal coherence. Trends Cogn Sci 2005, 9:474-480.
44. Cole M.W., Anticevic A., Repovs G., Barch D. Variable global dysconnectivity and individual differences in schizophrenia. Biol Psychiatry 2011, 70:43-50.
45. Uhlhaas P.J., Singer W. Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci 2010, 11:100-113.
46. Whittington M.A., Traub R.D., Kopell N., Ermentrout B., Buhl E.H. Inhibition-based rhythms: experimental and mathematical observations on network dynamics. Int J Psychophysiol 2000, 38:315-336.
47. Cardin J.A., Carlén M., Meletis K., Knoblich U., Zhang F., Deisseroth K., Tsai L.H., Moore C.I. Driving fast-spiking cells induces gamma rhythm and controls sensory responses. Nature 2009, 459:663-667.
48. Sohal V.S., Zhang F., Yizhar O., Deisseroth K. Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature 2009, 459:698-702.
49. Yizhar O., Fenno L.E., Prigge M., Schneider F., Davidson T.J., O'Shea D.J., Sohal V.S., Goshen I., Finkelstein J., Paz J.T., et al. Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature 2011, 477:171-178.
50. Spencer K.M., Niznikiewicz M.A., Shenton M.E., McCarley R.W. Sensory-evoked gamma oscillations in chronic schizophrenia. Biol Psychiatry 2008, 63:744-747.
51. Middleton S., Jalics J., Kispersky T., Lebeau F.E., Roopun A.K., Kopell N.J., Whittington M.A., Cunningham M.O. NMDA receptor-dependent switching between different gamma rhythm-generating microcircuits in entorhinal cortex. Proc Natl Acad Sci U S A 2008, 105:18572-18577.
52. Balu D.T., Basu A.C., Corradi J.P., Cacace A.M., Coyle J.T. The NMDA receptor co-agonists, d-serine and glycine, regulate neuronal dendritic architecture in the somatosensory cortex. Neurobiol Dis 2011, (e-pub).
53. Cahill M.E., Xie Z., Day M., Photowala H., Barbolina M.V., Miller C.A., Weiss C., Radulovic J., Sweatt J.D., Disterhoft J.F., et al. Kalirin regulates cortical spine morphogenesis and disease-related behavioral phenotypes. Proc Natl Acad Sci U S A 2009, 106:13058-13063.
54. Kocsis B. Differential role of NR2A and NR2B subunits in N-methyl-d-aspartate receptor antagonist-induced aberrant cortical gamma oscillations. Biol Psychiatry 2011, (e-pub).
55. McNally J.M., McCarley R.W., McKenna J.T., Yanagawa Y., Brown R.E. Complex receptor mediation of acute ketamine application on in vitro gamma oscillations in mouse prefrontal cortex: modeling gamma band oscillation abnormalities in schizophrenia. Neuroscience 2011, (e-pub).
56. Ramsey A.J., Milenkovic M., Oliveira A.F., Escobedo-Lozoya Y., Seshadri S., Salahpour A., Sawa A., Yasuda R., Caron M.G. Impaired NMDA receptor transmission alters striatal synapses and DISC1 protein in an age-dependent manner. Proc Natl Acad Sci U S A 2011, 108:5795-5800.
57. Powell S.B., Sejnowski T.J., Behrens M.M. Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia. Neuropharmacology 2011, (e-pub).
58. Moghaddam B., Javitt D. From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology 2011, 10.1038/npp.2011.181.
59. Vreugdenhil M., Jefferys J.G., Celio M.R., Schwaller B. Parvalbumin-deficiency facilitates repetitive IPSCs and gamma oscillations in the hippocampus. J Neurophysiol 2003, 89:1414-1422.
60. Eggan S.M., Lazarus M.S., Stoyak S.R., Volk D.W., Glausier J.R., Huang Z.J., Lewis D.A. Cortical glutamic acid decarboxylase 67 deficiency results in lower cannabinoid 1 receptor messenger RNA expression: implications for schizophrenia. Biol Psychiatry 2011, (e-pub).
61. Roepstorff A., Lambert J.D. Comparison of the effect of the GABA uptake blockers, tiagabine and nipecotic acid, on inhibitory synaptic efficacy in hippocampal CA1 neurones. Neurosci Lett 1992, 146:131-134.
62. Vierling-Claassen D., Siekmeier P., Stufflebeam S., Kopell N. Modeling GABA alterations in schizophrenia: a link between impaired inhibition and altered gamma and beta range auditory entrainment. J Neurophysiol 2008, 99:2656-2671.
63. Brown E.N., Lydic R., Schiff N.D. General anesthesia, sleep, and coma. N Engl J Med 2010, 363:2638-2650.
64. Ching S., Purdon P.L., Kopell N.J., Brown E.N. A neurophysiological-metabolic model for burst suppression. Proc Natl Acad Sci U S A 2012, 109:3095-3100.
65. McCarthy M.M., Brown E.N., Kopell N. Potential network mechanisms mediating electroencephalographic beta rhythm changes during propofol-induced paradoxical excitation. J Neurosci 2008, 28:13488-13504.
66. Gugino L.D., Chabot R.J., Prichep L.S., John E.R., Formanek V., Aglio L.S. Quantitative eeg changes associated with loss and return of consciousness in healthy adult volunteers anaesthetized with propofol or sevoflurane. Br J Anaesth 2001, 87:421-428.
67. Schiff N.D., Posner J.B. Another awakenings. Ann Neurol 2007, 62:5-7.
68. Schiff N.D. Recovery of consciousness after brain injury: a mesocircuit hypothesis. Trends Neurosci 2010, 33:1-9.
69. Schiff N.D. Circuit mechanisms underlying behavioral variability during recovery of consciousness following severe brain injury. The dynamic brain: an exploration of neuronal variability and its functional significance 2011, 279. ISBN-13: 9780195393798. Mingzhou Ding, Dennis Glanzman (Eds.).
70. Cimenser A., Purdon P.L., Pierce E.T., Walsh J.L., Salazar-Gomez A.F., Harrell P.G., Tavares-Stoeckel C., Habeeb K., Brown E.N. Tracking brain states under general anesthesia by using global coherence analysis. Proc Natl Acad Sci U S A 2011, 108:8832-8837.
71. Supp G.G., Siegel M., Hipp J.F., Engel A.K. Cortical hyper-synchrony predicts breakdown of sensory processing during loss of consciousness. Curr Biol 2011, 12:12.
72. Murphy M., Bruno M.-A., Riedner B.A., Boveroux P., Noirhomme Q., Landsness E.C., Brichant J.-F., Phillips C., Massimini M., Laureys S., et al. Propofol anesthesia and sleep: a high-density eeg study. Sleep 2011, 34:283-291.
73. Ching S., Cimenser A., Purdon P.L., Brown E.N., Kopell N.J. Thalamocortical model for a propofol-induced alpha-rhythm associated with loss of consciousness. Proc Natl Acad Sci U S A 2010, 107:22665-22670.
74. Sleigh J.W., Scheib C.M., Sanders R.D. General anaesthesia and electroencephalo-graphic spindles. Trends Anaesth Crit Care 2011, 1:263-269.
75. Kaplan P.W., Genoud D., Ho T.W., Jallon P. Etiology, neurologic correlations, and prognosis in alpha coma. Clin Neurophysiol 1999, 110:205-213.
76. Solt K., Cotten J.F., Cimenser A., Wong K.F.K., Chemali J.J., Brown E.N. Methylphenidate actively induces emergence from general anesthesia. Anesthesiology 2011, 115:791-803.
77. Sleigh J.W., Vizuete J.A., Voss L., Steyn-Ross A., Steyn-Ross M., Marcuccilli C.J., Hudetz A.G. The electrocortical effects of enflurane: experiment and theory. Anesth Analg 2009, 109:1253-1262.
78. Li D., Li X., Hagihira S., Sleigh J.W. The effect of isoflurane anesthesia on the electroencephalogram assessed by harmonic wavelet bicoherence-based indices. J Neural Eng 2011, 8:056011.
79. Talavera J.A., Esser S.K., Amzica F., Hill S., Antognini J.F. Modeling the gabaergic action of etomidate on the thalamocortical system. Anesth Analg 2009, 108:160-167.
80. Foster B.L., Liley D.T.J. Nitrous oxide paradoxically modulates slow electroencephalogram oscillations: implications for anesthesia monitoring. Anesth Analg 2011, 113:758-765.
81. Hutt A. Sleep and Anesthesia: Neural Correlates in Theory and Experiment 2011, Springer.
82. Foster B.L., Bojak I., Liley D.T.J. Population based models of cortical drug response: insights from anaesthesia. Cogn Neurodyn 2008, 2:283-296.
83. Ferrarelli F., Massimini M., Sarasso S., Casali A., Riedner B.A., Angelini G., Tononi G., Pearce R.A. Breakdown in cortical effective connectivity during midazolam-induced loss of consciousness. Proc Natl Acad Sci U S A 2010, 107:2681-2686.
84. Elliot Hong L., Summerfelt A., Buchanan R.W., O'Donnell P., Thaker G.K., Weiler M.A., Lahti A.C. Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine. Neuropsychopharmacology 2010, 35:632-640.
85. Lazarewicz M.T., Ehrlichman R.S., Maxwell C.R., Gandal M.J., Finkel L.H., Siegel S.J. Ketamine modulates theta and gamma oscillations. J Cogn Neurosci 2010, 22:1452-1464.
86. Fuchs E.C., Doheny H., Faulkner H., Caputi A., Traub R.D., Bibbig A., Kopell N., Whittington M.A., Monyer H. Genetically altered AMPA-type glutamate receptor kinetics in interneurons disrupt long-range synchrony of gamma oscillation. Proc Natl Acad Sci U S A 2001, 98:3571-3576.